000 01252 a2200349 4500
005 20250515075609.0
264 0 _c20070925
008 200709s 0 0 eng d
022 _a1110-0362
040 _aNLM
_beng
_cNLM
100 1 _aEl Serafi, Moustafa M
245 0 0 _aGemcitabine plus doxorubicin as first-line treatment in advanced or metastatic breast cancer (MBC), a phase II study.
_h[electronic resource]
260 _bJournal of the Egyptian National Cancer Institute
_cSep 2006
300 _a209-15 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
650 0 4 _aGemcitabine
700 1 _aEl Khodary, Ahmed I
700 1 _aEl Zawahry, Heba R
700 1 _aMansour, Osman M
700 1 _aGaballa, Hussein E
773 0 _tJournal of the Egyptian National Cancer Institute
_gvol. 18
_gno. 3
_gp. 209-15
999 _c17204233
_d17204233